Context Therapeutics (6K9.F) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.41
-0.28
-0.15
-0.03

Details

Expected EPS
-0.0847366
Actual EPS
-0.0276315
Surprise EPS
0.06
Surprise Percent
+67.39%

Description

Context Therapeutics (6K9.F) has reported earnings of -0.0276315 per share for Q1 2025.

0 Comments

Share your thoughts